Carlsmed, Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 30 →InsidersNo open-market buys. 1 insider sold $2.6M in 1 sale, with no 10b5-1 plan named.→HoldersJupiter Topco 4.6%Parkman Healthcare Partners 2.2%BlackRock 2.0%→Financing →PeersClosest companies: SI, SIBN, PRCT→
From the filings
Figures
- Revenue
- $63.3Mlast 12 months
- Net income
- −$36.3Mlast 12 months
- Operating cash flow
- −$33.8Mlast 12 months
- Cash and equivalents
- $46.2Mat the last balance sheet
- Total debt
- $15.4Mat the last balance sheet
- Shares outstanding
- 27.2M shareson issue